P

    Precision Optics Corporation, Inc. Common stock (POCI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $4.30
    -0.10 (-2.27%)

    Market Cap: $48.16M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.07
    Range$-0.07 - $-0.07
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$0.00+100.0%
    7d ago$0.00+100.0%
    Current$-0.07
    Revenue Consensus
    $8M
    Range$8M - $8M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-$-0.07---
    Mar 26
    		$-0.01N/AN/ABeat+95.4%
    Dec 25
    		$-0.23N/AN/ABeat-51.1%
    Sep 25
    		$-0.21N/AN/ABeat+8.7%
    Jun 25
    		$-0.18$0.00N/AMiss-244.8%
    Mar 25
    		$-0.30N/AN/ABeat-139.8%
    Dec 24
    		$-0.15$0.00N/ABeat-99.3%
    Sep 24
    		$-0.23$0.00N/ABeat-1275.1%
    Mar 24
    		$-0.05N/AN/ABeat+25.4%
    Dec 23
    		$-0.13N/AN/ABeat-217.0%
    Sep 23
    		$-0.08N/AN/ABeat-489.2%
    Jun 23
    		$-0.02N/AN/ABeat-184.5%
    Mar 23
    		$-0.07N/AN/ABeat-600.0%
    Dec 22
    		$0.11N/AN/ABeat+456.3%
    Sep 22
    		$-0.01N/AN/ABeat+67.5%
    Jun 22
    		$0.02$0.00N/ABeat+150.0%
    Mar 22
    		$-0.01$0.00N/AMiss-125.0%
    Dec 21
    		$-0.03$0.00N/AMiss-50.0%
    Sep 21
    		$-0.04$0.00N/AMiss-20100.0%
    Jun 21
    		$-0.04$0.00N/AMiss-100.0%
    Mar 21
    		$0.04$0.00N/ABeat+200.0%
    Dec 20
    		$-0.02$0.00N/AMiss+50.0%
    Sep 20
    		$0.00$0.00N/ABeat+102.0%
    Jun 20
    		$-0.02$0.00N/AMiss-100.0%
    Mar 20
    		$-0.04$0.00N/AMiss-300.0%
    Dec 19
    		$-0.04$0.00N/AMiss-300.0%
    Sep 19
    		$-0.01$0.00N/AMiss+66.7%
    Jun 19
    		$-0.01$0.00N/AMiss-300.0%
    Mar 19
    		$-0.01$0.00N/AMiss+66.7%
    Dec 18
    		$-0.01$0.00N/AMiss+44.8%
    Sep 18
    		$-0.03$0.00N/AMiss-215.8%
    Jun 18
    		$0.01$0.00N/ABeat+106.2%
    Mar 18
    		$-0.03$0.00N/AMiss+45.7%
    Dec 17
    		$-0.02N/AN/ABeat+84.3%
    Sep 17
    		$-0.01N/AN/ABeat+91.9%
    Jun 17
    		$-0.08N/AN/ABeat-
    Mar 17
    		$-0.06N/AN/ABeat-
    Dec 16
    		$-0.12N/AN/ABeat-
    Sep 16
    		$-0.12N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-6.75EV/EBITDA129.55x
    Price/FCF-17.02xFCF Yield-5.87%
    Profitability
    Profit Margin-17.00%Operating Margin-0.74%
    ROE-29.60%ROIC0.35%
    Financial Health
    Debt/Equity0.07xInterest Coverage0.35x
    Current Ratio2.10xQuick Ratio1.74x
    Trading Statistics
    Beta0.32Avg Volume48.76K
    52-Week High$6.1552-Week Low$3.55

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.41
    SMA 20$4.32
    SMA 50$4.56
    SMA 200$4.60
    EMA 10$4.37
    EMA 20$4.38
    EMA 50$4.52
    EMA 200$4.61

    MACD

    Line: -0.03Signal: -0.06Hist: 0.03

    ADX

    ADX: 22.5+DI: 20.9-DI: 9.6

    Aroon & PSAR

    Aroon Up80.0
    Aroon Down52.0
    PSAR$4.99

    Bollinger Bands

    Upper Band$4.54
    Lower Band$4.10
    %B Position1027%(Upper)
    Band Width0.45

    RSI (14-Day)

    Neutral
    45.3

    Momentum Oscillators

    Stoch %K31.7
    Stoch %D33.0
    Williams %R-76.2
    ROC (10d)2.9%
    Momentum0.12
    CCI (20d)-15.7
    MFI (14d)71.6

    Volatility Measures

    ATR (14d)$0.28(6.5%)
    StdDev (20d)0.11
    Hist Vol36.6%(Moderate)

    Volume Flow

    VWAP$4.33
    OBV611.8K
    AD Line-516.7K
    CMF (20d)-0.101

    Volume Metrics

    Avg Vol (20d)49.4K
    Vol Ratio0.2x(Low)
    VWMA (20d)$4.32

    Pivot Points

    R3$4.76
    R2$4.65
    R1$4.52
    Pivot Point$4.41
    S1$4.29
    S2$4.18
    S3$4.05

    Advanced Oscillators

    TSI-5.09
    Ultimate Osc30.9
    KST-18.27

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$8.71M$7.37M$6.68M$6.18M$4.19M$4.53M$4.20M$4.72M$5.24M$4.82M$4.32M$5.02M
    Cost of Revenue$6.65M$7.16M$5.73M$5.38M$3.77M$3.46M$3.08M$3.69M$3.38M$3.37M$2.86M$3.27M
    Gross Profit$2.06M$204,660$946,358$799,186$417,975$1.07M$1.12M$1.02M$1.86M$1.45M$1.46M$1.76M
    Operating Expenses$2.12M$1.95M$2.54M$2.16M$2.46M$1.98M$2.36M$2.38M$2.12M$2.16M$1.87M$4.11M
    R&D$267,319$249,574$311,840$228,315$211,242$317,747$400,659$354,522$192,773$221,728$212,758$630,736
    SG&A$1.85M$1.70M$2.23M$1.93M$2.25M$1.66M$1.96M$2.03M$1.92M$1.93M$1.66M$3.48M
    Operating Income$-64,462$-1,742,329$-1,595,255$-1,356,044$-2,038,285$-910,021$-1,246,941$-1,356,351$-258,527$-704,162$-405,293$-614,543
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$35,116$38,462$41,775$44,577$58,476$59,660$64,306$52,818$58,528$54,640$59,122$108,406
    Income Before Tax$-99,578$-1,780,791$-1,637,030$-1,400,621$-2,096,761$-969,681$-1,311,247$-1,409,169$-317,055$-758,802$-464,415$-1,892,354
    Income Tax Expense$8,705$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-108,283$-1,780,791$-1,637,030$-1,402,557$-2,096,761$-969,681$-1,311,247$-1,411,105$-317,055$-758,802$-464,415$-96,125
    EBITDA$15,749$-1,663,556$-1,525,466$-1,300,804$-1,975,927$-856,283$-1,194,275$-1,296,179$-201,826$-647,089$-349,353$-566,087
    EBIT$-64,462$-1,742,329$-1,595,255$-1,356,044$-2,038,285$-910,021$-1,246,941$-1,356,351$-258,527$-704,162$-405,293$-614,543
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about POCI

    Government Contracts

    Gov Obligations (TTM)
    $20895
    Gov Obligations / Revenue
    0.1%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    9.9 mo

    Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N98026P00631Department of Health and Human ServicesNational Institutes of Health$20895Jun 1, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Breaking News about Precision Optics Corporation, Inc. - Common stock (Nasdaq:POCI)

    This article provides recent news and upcoming earnings schedules for Precision Optics Corporation, Inc. (POCI). It lists various past and future earnings report dates, primarily sourced from Benzinga, and also includes a recent Q3 2026 earnings transcript from The Motley Fool. The current stock price and change are noted.

    FinancialContent•8/25/26•
    Neutral

    Precision Optics at Lytham Partners summit: growth shifts to scale By Investing.com

    Precision Optics (POCI) outlined its shift from infrastructure buildout to production scale at the Lytham Partners 2026 Consumer & Technology Investor Summit, driven by growth in satellite communications, single-use medical devices, and defense. The company highlighted significant revenue increases due to major programs moving into production, particularly in single-use endoscopy and a satellite communications program, despite a near-term inventory-related slowdown for one satellite customer. Management emphasized the company's unique ability to design and manufacture highly precise, small optical systems, positioning it for continued expansion into new markets and sustained growth from recurring demand and longer-term contracts.

    Investing.com Nigeria•8/19/26•
    Bullish

    POCI | Precision Optics Corporation, Inc. Financials - Revenue Breakdown

    This article provides an overview of Precision Optics Corporation, Inc. (POCI) financials, specifically focusing on revenue breakdown. It includes sections on insider trading, institutional holdings, corporate lobbying, and a summary of the company's business. The platform offers various financial data and tools for analyzing the stock, though specific revenue segment data for POCI is noted as unavailable.

    Quiver Quantitative•8/19/26•
    Neutral

    Precision Optics Corporation, Inc. Appoints Peter Thier as Senior Vice President of Sales and Marketing

    Precision Optics Corporation, Inc. has appointed Peter Thier as their new Senior Vice President of Sales and Marketing. Thier brings over 30 years of experience in sales, business development, and commercial leadership within the medical technology and life sciences industries. In this role, he will be responsible for spearheading the company's sales and marketing strategy to drive its next phase of growth.

    www.marketscreener.com•8/19/26•
    Bullish

    Precision Optics Appoints Peter Thier as Senior Vice President of Sales and Marketing

    Precision Optics Corporation has appointed Peter Thier as Senior Vice President of Sales and Marketing to bolster its commercial leadership and expand its reach in medical, defense, and aerospace markets. Thier brings over 30 years of experience in sales, business development, and commercial leadership within the medical technology and advanced product development industries. This strategic hire is expected to strengthen customer relationships and convert technical capabilities into long-term development and production programs.

    GlobeNewswire•8/19/26•
    Bullish

    Frequently Asked Questions About POCI

    Does POCI pay dividends?
    Precision Optics Corporation, Inc. Common stock (POCI) does not currently pay a regular dividend.
    What is POCI's market cap?
    Precision Optics Corporation, Inc. Common stock (POCI) has a market capitalization of $48.16M with a current stock price of $4.30.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In